28 October 2019 08:30-09:00
eApps and medical diagnostics data management
29 October 2019 14:00-14:45
Value and impact of laboratory medicine in healthcare delivery
29 October 2019 14:45-15:15
Lipid guidelines: emerging evidence on importance of non-fasting and postprandial lipids
Dr. Adeli is currently the head and full professor of Clinical Biochemistry at the Hospital for Sick Children and the Department of Laboratory Medicine & Pathobiology at the University of Toronto in Toronto. He is also Vice Chair of Quality in Laboratory Medicine and Pathobiology, and a Senior Associate Scientist in the Program in Molecular Medicine, Research Institute, The Hospital for Sick Children. Dr. Adeli is a fellow of the Canadian Academy of Clinical Biochemistry and a diplomate of the American Board of Clinical Biochemistry. He is currently the Editor-in-Chief of the Critical Reviews in Clinical Laboratory Sciences (2017 Impact Factor of 6.4). Dr. Adeli served as the Editor-in-Chief of the Clinical Biochemistry journal for 7 years (1999-2006). He has received several distinctions and careers awards. Most recently, the 2019 AACC Academy Research Award, the 2017 Graduate Teaching Award, Laboratory Medicine and Pathobiology, University of Toronto, the 2016 Senior Investigator Award of the Canadian Lipoprotein Conference, the 2015 AACC Pediatric-Maternal-Fetal Division Award, the 2015 Canadian Society of Clinical Chemists Innovation Award (CSCC), and the 2015 Ontario Society of Clinical Chemists (OSCC) Lifetime Achievement Award.
Dr. Adeli has been actively involved in both molecular and clinical laboratory research since 1988 and has published over 500 articles and abstracts to date. His main area of research is focused on understanding the pathophysiology of obesity, metabolic syndrome and type 2 diabetes. Specifically, his laboratory is investigating the neuroendocrine mechanisms regulating intestinal and hepatic lipoprotein overproduction in insulin resistant states and the role of the gut-brain-liver axis in lipid and lipoprotein metabolism. Dr. Adeli is also active in clinical chemistry research and has been involved in a number of projects on diagnostic test development projects. He is the principal investigator of the CALIPER (Canadian Laboratory Initiative on Pediatric Reference Interval Database) project aimed at the establishment of a laboratory reference interval database for biomarkers of pediatric disease. The CALIPER database is now used in hospitals across Canada and around the world to improve diagnosis and monitoring of children with medical concerns.
Papillon Zeugma Convention Centre, Belek Antalya - TURKEY
October 27-31, 2019